Search Results - "Audebert, Christine"
-
1
Reference intervals of bone turnover markers in healthy premenopausal women: Results from a cross-sectional European study
Published in Bone (New York, N.Y.) (01-05-2012)“…Abstract Robust validated reference intervals for bone turnover markers (BTMs) are required to assess fracture risk and effectiveness of therapy. However,…”
Get full text
Journal Article -
2
Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette
Published in Journal of pharmacy & pharmaceutical sciences (01-07-2016)“…A randomized cross-over, double blind placebo controlled study of smoked cannabis was carried out on occasional cannabis smokers. The objective of this…”
Get full text
Journal Article -
3
Antiparkinsonian drug‐induced sleepiness: a double‐blind placebo‐controlled study of L‐dopa, bromocriptine and pramipexole in healthy subjects
Published in British journal of clinical pharmacology (01-03-2009)“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Dopamine agonists used in Parkinson's disease patients are associated with excessive daytime sleepiness and sleep…”
Get full text
Journal Article -
4
Neurobehavioral and Cognitive Changes Induced by Hypoxia in Healthy Volunteers
Published in CNS & neurological disorders drug targets (01-01-2016)“…The early assessment of new symptomatic drugs against Alzheimer's disease remains difficult because of the lack of a predictive end-point. The use of a battery…”
Get more information
Journal Article -
5
Leptin and insulin in young adulthood are associated with weight in infancy
Published in Journal of endocrinology (01-02-2020)“…Low weight in early infancy is a known risk factor for cardio-metabolic syndrome in adult life. However, little is known either about developmental programming…”
Get full text
Journal Article -
6
An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Published in Journal of clinical psychopharmacology (01-05-2020)“…Alzheimer disease (AD) is a public health issue because of the low number of symptomatic drugs and the difficulty to diagnose it at the prodromal stage. The…”
Get full text
Journal Article -
7
Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation
Published in Brain topography (01-05-2018)“…Resting-state connectivity has been widely studied in the healthy and pathological brain. Less well-characterized are the brain networks altered during…”
Get full text
Journal Article -
8
Abstract CT209: A phase I study with the oral pan-CDK inhibitor BAY 1000394 in patients with advanced stage small cell lung or ovarian cancer
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Background: BAY 1000394 (BAY) is an oral pan-CDK inhibitor targeting CDKs 1, 2, 4, 7 and 9 in the low nanomolar range. The recommended phase 2 dose…”
Get full text
Journal Article -
9
A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers
Published in Journal of clinical psychopharmacology (01-06-2006)“…Short-acting hypnotic drugs, such as zolpidem, have minimal residual effects but may not provide optimal efficacy throughout the night for all insomnia…”
Get full text
Journal Article -
10
Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies
Published in Psychopharmacologia (01-12-2009)“…Rationale Dimethylaminoethanol pyroglutamate (DMAE p-Glu) is a compound resulting from the reaction between dimethylaminoethanol (an indirect precursor of…”
Get full text
Journal Article -
11
Transdermal Alcohol Measurements Using MOX Sensors in Clinical Trials
Published in Proceedings (01-08-2017)“…Human metabolism often results in the emission of many VOCs through the skin. Ethanol is one of volatile compounds which are evaporated by perspiration. The…”
Get full text
Journal Article -
12
Oral MEK1/MEK2 inhibitor trametinib (GSK1120212) in combination with docetaxel in KRAS -mutant and wild-type (WT) advanced non-small cell lung cancer (NSCLC): A phase I/Ib trial
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 8028 Background: KRAS-mutant NSCLC, usually reflecting tobacco-related carcinogenesis, represents an unmet medical need in lung cancer therapy…”
Get full text
Journal Article -
13